SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-22-001819
Filing Date
2022-05-27
Accepted
2022-05-27 16:40:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13D sc13da413392002_05272022.htm SC 13D/A 76004
  Complete submission text file 0000921895-22-001819.txt   77466
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51477 | Film No.: 22978369
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address
Ma-Weaver Jacob (Filed by) CIK: 0001922140 (see all company filings)

Type: SC 13D/A